Ferumoxytol as an intraprostatic MR contrast agent for lymph node mapping of the prostate: a feasibility study in non-human primates

Abstract

Background

A variety of magnetic resonance (MR) lymphographic agents have been proposed for mapping the lymph nodes draining the prostate.

Purpose

To investigate the feasibility of using ferumoxytol (an FDA-approved iron oxide agent) for lymph node mapping of the prostate on imaging (MRI) in a non-human primate (NHP) Macaque model.

Material and Methods

Four NHPs weighing 5–13 kg underwent injection of ferumoxytol after a needle was introduced transrectally under MRI guidance into the prostate using a commercially available intrarectal MRI biopsy guide. Ferumoxytol was administered at dosage in the range of 0.15–0.75 mg Fe/kg in a fixed injection volume of 0.2 mL. T1-weighted MRI was performed at 3 T starting immediately and extending at least 45 min post-injection. Two readers evaluated the images in consensus. The NHPs tolerated the ferumoxytol injections at all doses with no evident side effects.

Results

It was determined that the lowest dose of 0.15 mg Fe/kg produced the best outcome in terms of lymph node visualization and draining nodes were reliably visualized at this dose and volume.

Conclusion

Thus, MRI with intraprostatic injection of ferumoxytol may be considered an effective T1 contrast agent for prospective mapping of lymph nodes draining the prostate and, thus, for attempted sentinel lymph node identification in prostate cancer. Large clinical trials to determine safety and efficacy are needed.

Keywords

Ferumoxytol lymph node prostate cancer iron oxide nanoparticles magnetic resonance imaging (MRI)

Get full access to this article

View all access options for this article.

References

Naselli

Andreatta

Introini

. Predictors of symptomatic lymphoceles after lymph node excision and radical prostatectomy. Urology 2010; 75: 630–635.

Liss

Palazzi

Stroup

. Outcomes and complications of pelvic lymph node dissection during robotic-assisted radical prostatectomy. World J Urol 2013; 31: 481–488.

Manny

Patel

Hemal

. Fluorescence-enhanced robotic radical prostatectomy using real-time lymphangiography and tissue marking with percutaneous injection of unconjugated indocyanine green: the initial clinical experience in 50 patients. Eur Urol 2014; 65: 1162–1168.

Turkbey

Hoyt

Agarwal

. Magnetic resonance lymph node mapping of the prostate after intraprostatic injection of Gadofosveset trisodium and albumin: Preliminary results in a canine model. Acad Radiol 2015; 22: 646–652.

Fortuin

Smeenk

Meijer

. Lymphotropic nanoparticle-enhanced MRI in prostate cancer: Value and therapeutic potential. Curr Urol Rep 2014; 15: 389–389.

Bashir

Bhatti

Marin

Nelson

. Emerging applications for ferumoxytol as a contrast agent in MRI. J Magn Reson Imaging 2014; 41: 884–898.

Smedley

Turkbey

Bernardo

. Tracking the luminal exposure and lymphatic drainage pathways of intravaginal and intrarectal inocula used in nonhuman primate models of HIV transmission. PLoS One 2014; 9: e92830–e92830.

Shiozawa

Lefor

Hozumi

. Sentinel lymph node biopsy in patients with breast cancer using superparamagnetic iron oxide and a magnetometer. Breast Cancer 2013; 20: 223–229.

Winter

Woenkhaus

Wawroschek

. A novel method for intraoperative sentinel lymph node detection in prostate cancer patients using superparamagnetic iron oxide nanoparticles and a handheld magnetometer: The initial clinical experience. Ann Surg Oncol 2014; 21: 4390–4396.